Tavneos European Union - Icelandic - EMA (European Medicines Agency)

tavneos

vifor fresenius medical care renal pharma france - avacopan - microscopic polyangiitis; wegener granulomatosis - Ónæmisbælandi lyf - tavneos, in combination with a rituximab or cyclophosphamide regimen, is indicated for the treatment of adult patients with severe, active granulomatosis with polyangiitis (gpa) or microscopic polyangiitis (mpa).

Idotrim Filmuhúðuð tafla 160 mg Iceland - Icelandic - LYFJASTOFNUN (Icelandic Medicines Agency)

idotrim filmuhúðuð tafla 160 mg

orion corporation (i)* - trimethoprimum inn - filmuhúðuð tafla - 160 mg

Idotrim Filmuhúðuð tafla 100 mg Iceland - Icelandic - LYFJASTOFNUN (Icelandic Medicines Agency)

idotrim filmuhúðuð tafla 100 mg

orion corporation (i)* - trimethoprimum inn - filmuhúðuð tafla - 100 mg

Darazíð Tafla 20 mg/12,5 mg Iceland - Icelandic - LYFJASTOFNUN (Icelandic Medicines Agency)

darazíð tafla 20 mg/12,5 mg

actavis group ptc ehf. - enalaprilum maleat; hydrochlorothiazidum inn - tafla - 20 mg/12,5 mg

Glimeryl Tafla 1 mg Iceland - Icelandic - LYFJASTOFNUN (Icelandic Medicines Agency)

glimeryl tafla 1 mg

teva b.v.* - glimepiride - tafla - 1 mg

Glimeryl Tafla 2 mg Iceland - Icelandic - LYFJASTOFNUN (Icelandic Medicines Agency)

glimeryl tafla 2 mg

teva b.v.* - glimepiride - tafla - 2 mg

Glimeryl Tafla 3 mg Iceland - Icelandic - LYFJASTOFNUN (Icelandic Medicines Agency)

glimeryl tafla 3 mg

teva b.v.* - glimepiride - tafla - 3 mg

Glimeryl Tafla 4 mg Iceland - Icelandic - LYFJASTOFNUN (Icelandic Medicines Agency)

glimeryl tafla 4 mg

teva b.v.* - glimepiride - tafla - 4 mg